{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Helicobacter pylori", "NOD2", "TP53", "Chronic gastritis", "DNA variants", "Familial gastric cancer", "Intestinal type of gastric cancer", "Molecular diagnostics"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38867324", "DateRevised": {"Year": "2024", "Month": "06", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["9", "10.1186/s13053-024-00282-8"], "ArticleDate": [{"Year": "2024", "Month": "06", "Day": "12"}], "Journal": {"ISSN": "1731-2302", "JournalIssue": {"Volume": "22", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jun", "Day": "12"}}, "Title": "Hereditary cancer in clinical practice", "ISOAbbreviation": "Hered Cancer Clin Pract"}, "ArticleTitle": "Mutations in Helicobacter pylori infected patients with chronic gastritis, intestinal type of gastric cancer and familial gastric cancer.", "Pagination": {"StartPage": "9", "MedlinePgn": "9"}, "Abstract": {"AbstractText": ["Development of sequential changes of mucous leading to gastric cancer and familial cases of gastric cancer of intestinal type is widely connected with Helicobacter pylori infections. In this study we analysed variants of genes involved in cancerogenesis and inflammatory processes of intestines in patients infected with H.pylori. Our goal was to test whether mutations in these genes predestinate to development of gastric cancer, and whether there is a genetic factor that makes it more likely for infections with H.pylori to cause gastric cancer. As infections with H. pylori are relatively common, discovering such genetic predispositions could be used for establishing risk-groups and for planning treatments.", "Our studies cover analysis of variants in genes involved in cancerogenesis: TP53 (rs11540652, rs587782329, COSM10771), MSH2 (rs193922376), MLH1 (rs63750217), and inflammatory processes of intestine: NOD2 (rs2066847, rs2066842), IL1A (rs1800587) and IL1B (rs1143634) from H.pylori-infected patients.", "Mutations were more common in the group of patients with gastric cancer of intestinal type and familial cases of gastric cancer in comparison with patients with chronic gastritis, chronic atrophic gastritis, intestinal metaplasia, dysplasia or gastric cancer (p-value\u2009=\u20090.00824), with the prevalence of p53 mutations in patients with familial gastric cancer vs. patients with other changes of mucosa (p-value\u2009=\u20090.000049). Additionally, gastric cancer patients have mainly genotype TT or CT of the rs2066842 variant of the NOD2 gene.", "The lack of statistically significant changes of other interleukin genes involved in inflammatory processes may suggest the presence of H.pylori infection as a potential trigger for the development of the inflammatory process of the mucosa, leading through microbiota dysbiosis to the development of enteric gastric cancer. Mutations in analysed genes correlated with more severe mucosal changes, with a much more frequent presence of TP53 gene mutations, with a limited presence of other mutations in the familial history of gastric cancer."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Independent Public Health Care Centre in Nowa Sol, Multispecialty Hospital, Chalubinskiego 7, Nowa Sol, 67-100, Poland."}], "LastName": "Hnatyszyn", "ForeName": "Andrzej", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Biotechnology, Pozna\u0144 University of Life Sciences, Dojazd 11, Pozna\u0144, 60-632, Poland."}], "LastName": "Szalata", "ForeName": "Marlena", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants National Research Institute, Wojska Polskiego 71B, Pozna\u0144, 60-630, Poland."}], "LastName": "Zieli\u0144ska", "ForeName": "Aleksandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna 27/33, Pozna\u0144, 60-572, Poland."}], "LastName": "Wielgus", "ForeName": "Karolina", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna 27/33, Pozna\u0144, 60-572, Poland."}], "LastName": "Danielewski", "ForeName": "Miko\u0142aj", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Pomeranian Medical University, Rybacka 1, Szczecin, 70-204, Poland."}], "LastName": "Hnatyszyn", "ForeName": "Piotr Tomasz", "Initials": "PT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Human Genetics, Polish Academy of Sciences, Strzeszy\u0144ska 32, Pozna\u0144, 60-479, Poland."}, {"Identifier": [], "Affiliation": "Department of General, Endocrinological Surgery and Gastrointestinal Oncology, Institute of Surgery, Poznan University of Medical Sciences, Przybyszewskiego 49, Pozna\u0144, 60-355, Poland."}], "LastName": "P\u0142awski", "ForeName": "Andrzej", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Szpitalna 27/33, Pozna\u0144, 60-572, Poland."}], "LastName": "Walkowiak", "ForeName": "Jaros\u0142aw", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants National Research Institute, Wojska Polskiego 71B, Pozna\u0144, 60-630, Poland. ryszard.slomski@up.poznan.pl."}, {"Identifier": [], "Affiliation": "Institute of Human Genetics, Polish Academy of Sciences, Strzeszy\u0144ska 32, Pozna\u0144, 60-479, Poland. ryszard.slomski@up.poznan.pl."}], "LastName": "S\u0142omski", "ForeName": "Ryszard", "Initials": "R"}], "GrantList": [{"GrantID": "508.181.00", "Agency": "Poznan University of Life Sciences", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Poland", "MedlineTA": "Hered Cancer Clin Pract", "NlmUniqueID": "101231179", "ISSNLinking": "1731-2302"}, "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. doi: 10.3322/CAAC.21660.", "ArticleIdList": ["10.3322/CAAC.21660", "33538338"]}, {"Citation": "Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, et al. Molecular landscapes of gastric pre-neoplastic and pre-invasive lesions. Int J Mol Sci. 2021;22. 10.3390/IJMS22189950.", "ArticleIdList": ["PMC8468646", "34576114"]}, {"Citation": "Shimizu T, Marusawa H, Watanabe N, Chiba T. Molecular pathogenesis of Helicobacter pylori-related gastric cancer. Gastroenterol Clin North Am. 2015;44. 10.1016/J.GTC.2015.05.011.", "ArticleIdList": ["26314672"]}, {"Citation": "Salvatori S, Marafini I, Laudisi F, Monteleone G, Stolfi C. Helicobacter pylori and gastric cancer: pathogenetic mechanisms. Int J Mol Sci. 2023;24. 10.3390/IJMS24032895.", "ArticleIdList": ["PMC9917787", "36769214"]}, {"Citation": "Li J, Kuang XH, Zhang Y, Hu DM, Liu K. Global burden of gastric Cancer in adolescents and young adults: estimates from GLOBOCAN 2020. Public Health. 2022;210:58\u201364. doi: 10.1016/J.PUHE.2022.06.010.", "ArticleIdList": ["10.1016/J.PUHE.2022.06.010", "35870322"]}, {"Citation": "Alipour M. Molecular mechanism of Helicobacter Pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021;52:23\u201330. doi: 10.1007/S12029-020-00518-5.", "ArticleIdList": ["10.1007/S12029-020-00518-5", "PMC7487264", "32926335"]}, {"Citation": "Blanchet A, Bourgmayer A, Kurtz JE, Mellitzer G, Gaiddon C. Isoforms of the P53 family and gastric Cancer: a M\u00e9nage \u00e0 Trois for an unfinished Affair. Cancers (Basel) 2021;13:1\u201345. doi: 10.3390/CANCERS13040916.", "ArticleIdList": ["10.3390/CANCERS13040916", "PMC7926742", "33671606"]}, {"Citation": "Marghalani A, Bin Salman T, Faqeeh F, Asiri M, Kabel A. Gastric carcinoma: insights into risk factors, methods of diagnosis, Possible Lines of Management, and the role of primary care. J Family Med Prim Care. 2020;9:2659. doi: 10.4103/JFMPC.JFMPC_527_20.", "ArticleIdList": ["10.4103/JFMPC.JFMPC_527_20", "PMC7491774", "32984103"]}, {"Citation": "Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3. 10.1038/NRDP.2017.36.", "ArticleIdList": ["28569272"]}, {"Citation": "Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, Malfertheiner P, M\u00e9graud F, Piscoya A, Quach D, et al. Helicobacter pylori World Gastroenterology Organization Global Guideline. J Clin Gastroenterol. 2023;57:111\u201326. doi: 10.1097/MCG.0000000000001719.", "ArticleIdList": ["10.1097/MCG.0000000000001719", "36598803"]}, {"Citation": "Rawla P, Barsouk A. Epidemiology of gastric Cancer: global trends, risk factors and Prevention. Prz Gastroenterol. 2019;14:26\u201338. doi: 10.5114/PG.2018.80001.", "ArticleIdList": ["10.5114/PG.2018.80001", "PMC6444111", "30944675"]}, {"Citation": "Luu MN, Quach DT, Hiyama T. Screening and surveillance for gastric Cancer: does Family History play an important role in shaping our strategy? Asia Pac J Clin Oncol. 2022;18:353\u201362. doi: 10.1111/AJCO.13704.", "ArticleIdList": ["10.1111/AJCO.13704", "34811928"]}, {"Citation": "Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter Pylori in Pathogenesis and Prevention efforts. Postgrad Med J. 2016;92:471\u20137. doi: 10.1136/POSTGRADMEDJ-2016-133997.", "ArticleIdList": ["10.1136/POSTGRADMEDJ-2016-133997", "27222587"]}, {"Citation": "Fedorowicz S, Radzikowska K, Mende K, Ferenc S, Gnus J. Helicobacter Pylori: historical therapy and current treatment. Nurs Public Health. 2020;10:49\u201355. doi: 10.17219/PZP/118082.", "ArticleIdList": ["10.17219/PZP/118082"]}, {"Citation": "Poorolajal J, Moradi L, Mohammadi Y, Cheraghi Z, Gohari-Ensaf F. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health. 2020;42. 10.4178/EPIH.E2020004.", "ArticleIdList": ["PMC7056944", "32023777"]}, {"Citation": "Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric Cancer: Lauren classification, mucin phenotype expression, and Cancer Stem cells. Int J Clin Oncol. 2019;24:771\u20138. doi: 10.1007/S10147-019-01443-9.", "ArticleIdList": ["10.1007/S10147-019-01443-9", "30980196"]}, {"Citation": "Wu R, Yang C, Ji L, Fan ZN, Tao YW, Zhan Q. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric. BMC Cancer. 2020;20. 10.1186/S12885-020-07612-8.", "ArticleIdList": ["PMC7670663", "33198658"]}, {"Citation": "Hnatyszyn A, Szalata M, Skrzypczak-Zielinska M, Wielgus K, Stanczyk J, Dziuba I, Mikstacki A, Dobrowolska A, Waszak M, Hnatyszyn PT, et al. DNA variants in Helicobacter Pylori infected patients with chronic gastritis, dysplasia and gastric Cancer. Adv Med Sci. 2018;64:79\u201384. doi: 10.1016/J.ADVMS.2018.12.002.", "ArticleIdList": ["10.1016/J.ADVMS.2018.12.002", "30553995"]}, {"Citation": "Hnatyszyn A, Wielgus K, Kaczmarek-Rys M, Skrzypczak-Zielinska M, Szalata M, Mikolajczyk-Stecyna J, Stanczyk J, Dziuba I, Mikstacki A, Slomski R. Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz). 2013;61. 10.1007/S00005-013-0245-Y.", "ArticleIdList": ["PMC3898137", "23995914"]}, {"Citation": "Hnatyszyn A, Szalata M, Stanczyk J, Cichy W, Slomski R. Association of c.802C\u2009&gt;\u2009T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to Cancer in H. Pylori infected patients. Exp Mol Pathol. 2010;88:388\u201393. doi: 10.1016/J.YEXMP.2010.03.003.", "ArticleIdList": ["10.1016/J.YEXMP.2010.03.003", "20230816"]}, {"Citation": "Boland CR, Yurgelun MB. Historical perspective on familial gastric Cancer. Cell Mol Gastroenterol Hepatol. 2017;3:192\u2013200. doi: 10.1016/J.JCMGH.2016.12.003.", "ArticleIdList": ["10.1016/J.JCMGH.2016.12.003", "PMC5331778", "28275686"]}, {"Citation": "Boveri T, Boveri M. The origin of malignant tumors. Bailli\u00e8re: Tindall and Cox: London; 1929."}, {"Citation": "Gigek CO, Calcagno DQ, Rasmussen LT, Santos LC, Leal MF, Wisnieski F, Burbano RR, Louren\u00e7o LG, Lopes-Filho GJ, Smith MAC. Genetic variants in gastric Cancer: risks and clinical implications. Exp Mol Pathol. 2017;103:101\u201311. doi: 10.1016/J.YEXMP.2017.07.004.", "ArticleIdList": ["10.1016/J.YEXMP.2017.07.004", "28736214"]}, {"Citation": "Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-Cadherin gene predict poor survival of patients with gastric Cancer. J Clin Oncol. 2013;31:868\u201375. doi: 10.1200/JCO.2012.44.4612.", "ArticleIdList": ["10.1200/JCO.2012.44.4612", "23341533"]}, {"Citation": "Go MF, Review, Article Natural history and epidemiology of Helicobacter Pylori Infection. Aliment Pharmacol Ther. 2002;16(Suppl 1):3\u201315. doi: 10.1046/J.1365-2036.2002.0160S1003.X.", "ArticleIdList": ["10.1046/J.1365-2036.2002.0160S1003.X", "11849122"]}, {"Citation": "Graham DY. Helicobacter Pylori Update: gastric Cancer, Reliable Therapy, and possible benefits. Gastroenterology. 2015;148:719\u2013e7313. doi: 10.1053/J.GASTRO.2015.01.040.", "ArticleIdList": ["10.1053/J.GASTRO.2015.01.040", "PMC4375058", "25655557"]}, {"Citation": "Szymczak A, Ferenc S, Majewska J, Miernikiewicz P, Gnus J, Witkiewicz W, D\u0105browska K. Application of 16S rRNA gene sequencing in Helicobacter pylori detection. PeerJ. 2020;2020. 10.7717/PEERJ.9099/SUPP-10.", "ArticleIdList": ["PMC7229771", "32440373"]}, {"Citation": "Da Costa DM, Dos Santos Pereira E, Rabenhorst SHB. What exists beyond CagA and VacA? Helicobacter Pylori genes in gastric diseases. World J Gastroenterology: WJG. 2015;21:10563. doi: 10.3748/WJG.V21.I37.10563.", "ArticleIdList": ["10.3748/WJG.V21.I37.10563", "PMC4588078", "26457016"]}, {"Citation": "Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric Cancer after detection of Helicobacter Pylori infection: a large cohort study. Gastroenterology. 2020;158:527\u2013e5367. doi: 10.1053/J.GASTRO.2019.10.019.", "ArticleIdList": ["10.1053/J.GASTRO.2019.10.019", "PMC7010558", "31654635"]}, {"Citation": "Valenzuela MA, Canales J, Corval\u00e1n AH, Quest AFG. Helicobacter Pylori-Induced inflammation and epigenetic changes during Gastric Carcinogenesis. World J Gastroenterol. 2015;21:12742. doi: 10.3748/WJG.V21.I45.12742.", "ArticleIdList": ["10.3748/WJG.V21.I45.12742", "PMC4671030", "26668499"]}, {"Citation": "Zhou XZ, Lyu NH, Zhu HY, Cai QC, Kong XY, Xie P, Zhou LY, Ding SZ, Li ZS, Du YQ. Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention. Gut. 2023;72. 10.1136/GUTJNL-2022-328965.", "ArticleIdList": ["PMC10086479", "36690433"]}, {"Citation": "Rustgi SD, Oh A, Hur C. Testing and treating Helicobacter Pylori infection in individuals with family history of gastric Cancer is cost-effective. Gastroenterology. 2021;161:2051\u2013e20524. doi: 10.1053/J.GASTRO.2021.08.042.", "ArticleIdList": ["10.1053/J.GASTRO.2021.08.042", "34461053"]}, {"Citation": "Choi IJ, Kim CG, Lee JY, Kim Y-I, Kook M-C, Park B, Joo J. Family History of Gastric Cancer and Helicobacter Pylori Treatment. N Engl J Med. 2020;382:427\u201336. doi: 10.1056/NEJMOA1909666.", "ArticleIdList": ["10.1056/NEJMOA1909666", "31995688"]}, {"Citation": "Caguazango JC. Ecological models of gastric microbiota dysbiosis: Helicobacter Pylori and gastric carcinogenesis. Med Microecology. 2020;3:100010. doi: 10.1016/J.MEDMIC.2020.100010.", "ArticleIdList": ["10.1016/J.MEDMIC.2020.100010"]}, {"Citation": "Vinasco K, Mitchell HM, Kaakoush NO, Casta\u00f1o-Rodr\u00edguez N. Microbial carcinogenesis: lactic acid bacteria in gastric cancer. Biochim Biophys Acta Rev Cancer. 2019;1872. 10.1016/J.BBCAN.2019.07.004.", "ArticleIdList": ["31394110"]}, {"Citation": "Li Y, Hu Y, Zhan X, Song Y, Xu M, Wang S, Huang X, Xu ZZ. Meta-analysis reveals Helicobacter Pylori Mutual Exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression. Gut Microbes. 2023;15:2197835. doi: 10.1080/19490976.2023.2197835.", "ArticleIdList": ["10.1080/19490976.2023.2197835", "PMC10078126", "37020297"]}, {"Citation": "Padda J, Khalid K, Cooper AC, Jean-Charles G. Association between Helicobacter pylori and gastric carcinoma. Cureus. 2021;13. 10.7759/CUREUS.15165.", "ArticleIdList": ["PMC8216031", "34168929"]}, {"Citation": "Negovan A, Iancu M, F\u00fcl\u00f6p E, B\u01cenescu C. Helicobacter Pylori and Cytokine Gene Variants as predictors of Premalignant gastric lesions. World J Gastroenterol. 2019;25:4105. doi: 10.3748/WJG.V25.I30.4105.", "ArticleIdList": ["10.3748/WJG.V25.I30.4105", "PMC6700706", "31435167"]}, {"Citation": "Ma J, Wu D, Hu X, Li J, Cao M, Dong W. Associations between cytokine gene polymorphisms and susceptibility to Helicobacter pylori infection and Helicobacter pylori related gastric pancer, peptic ulcer disease: a meta-analysis. PLoS ONE. 2017;12. 10.1371/JOURNAL.PONE.0176463.", "ArticleIdList": ["PMC5409176", "28453551"]}, {"Citation": "Melchiades JL, Zabaglia LM, Sallas ML, Orcini WA, Chen E, Smith MAC, Pay\u00e3o SLM, Rasmussen LT. Polymorphisms and haplotypes of the interleukin 2 Gene Are Associated with an increased risk of gastric Cancer. The possible involvement of Helicobacter Pylori. Cytokine. 2017;96:203\u20137. doi: 10.1016/J.CYTO.2017.04.020.", "ArticleIdList": ["10.1016/J.CYTO.2017.04.020", "28458166"]}, {"Citation": "El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al. Interleukin-1 Polymorphisms Associated with increased risk of gastric Cancer. Nature. 2000;404:398\u2013402. doi: 10.1038/35006081.", "ArticleIdList": ["10.1038/35006081", "10746728"]}, {"Citation": "Persson C, Canedo P, MacHado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their Association with gastric Cancer: a HuGE systematic review and Meta-analyses. Am J Epidemiol. 2011;173:259. doi: 10.1093/AJE/KWQ370.", "ArticleIdList": ["10.1093/AJE/KWQ370", "PMC3105271", "21178102"]}, {"Citation": "Zabaglia LM, Rays MS, de Labio RW, Neto AC, Pay\u00e3o SLM, Rasmussen LT. Association between Interleukin-1\u03b2 polymorphisms and gastric disease in children: a correlation with Helicobacter Pylori. Asian Pac J Trop Dis. 2016;6:722\u20135. doi: 10.1016/S2222-1808(16)61117-9.", "ArticleIdList": ["10.1016/S2222-1808(16)61117-9"]}, {"Citation": "Santos JC, Ladeira MSP, Pedrazzoli J, Ribeiro ML. Relationship of IL-1 and TNF-\u03b1 polymorphisms with Helicobacter Pylori in gastric diseases in a Brazilian Population. Braz J Med Biol Res. 2012;45:811\u20137. doi: 10.1590/S0100-879X2012007500099.", "ArticleIdList": ["10.1590/S0100-879X2012007500099", "PMC3854325", "22714811"]}, {"Citation": "Yuan XY, Zhang Y, Zhao X, Chen A, Liu P. IL-1\u03b2, an important cytokine affecting Helicobacter pylori-mediated gastric carcinogenesis. Microb Pathog. 2023;174. 10.1016/J.MICPATH.2022.105933.", "ArticleIdList": ["36494022"]}, {"Citation": "De Brito BB, Da Silva FAF, De Melo FF. Role of polymorphisms in genes that encode cytokines and Helicobacter Pylori virulence factors in gastric carcinogenesis. World J Clin Oncol. 2018;9:83\u20139. doi: 10.5306/WJCO.V9.I5.83.", "ArticleIdList": ["10.5306/WJCO.V9.I5.83", "PMC6153128", "30254963"]}, {"Citation": "Furuta T, Elomar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1\u03b2 polymorphisms increase risk of Hypochlorhydria and Atrophic Gastritis and reduce risk of duodenal Ulcer recurrence in Japan. Gastroenterology. 2002;123:92\u2013105. doi: 10.1053/gast.2002.34156.", "ArticleIdList": ["10.1053/gast.2002.34156", "12105837"]}, {"Citation": "El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, et al. Increased risk of Noncardia Gastric Cancer Associated with Proinflammatory Cytokine Gene Polymorphisms. Gastroenterology. 2003;124:1193\u2013201. doi: 10.1016/S0016-5085(03)00157-4.", "ArticleIdList": ["10.1016/S0016-5085(03)00157-4", "12730860"]}, {"Citation": "Lobo Gatti L, Rodr\u00edguez Burbano R, De Pimentel P, De Arruda Cardoso Smith M, Marques Pay\u00e3o SL. Interleukin-1beta polymorphisms, Helicobacter Pylori infection in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med. 2004;4:93\u20138. doi: 10.1007/S10238-004-0043-2.", "ArticleIdList": ["10.1007/S10238-004-0043-2", "15672946"]}, {"Citation": "Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, et al. Helicobacter Pylori and Interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680\u20137. doi: 10.1093/JNCI/94.22.1680.", "ArticleIdList": ["10.1093/JNCI/94.22.1680", "12441323"]}, {"Citation": "Li J, Wang F, Zhou Q, Ou Z, Jia H, Deng X, He Y, Wu X. IL-1 polymorphisms in children with peptic symptoms in South China. Helicobacter. 2011;16:246\u201351. doi: 10.1111/J.1523-5378.2011.00837.X.", "ArticleIdList": ["10.1111/J.1523-5378.2011.00837.X", "21585612"]}, {"Citation": "He W, Liu T, Shan Y, Zhu K, Li Y. PARP1 polymorphisms increase the risk of gastric Cancer in a Chinese Population. Mol Diagn Ther. 2012;16:35\u201342. doi: 10.1007/BF03256428.", "ArticleIdList": ["10.1007/BF03256428", "22221038"]}, {"Citation": "Mukherjee S, Ghatak S, Chhuani L, Lalrinpuia B, Jahau L, Pautu JL, Sarmah M, Kumar NS. Helicobacter Pylori virulent genes and Host Interleukin 1 are Associated with demographic factors for an increased risk of Gastritis. Hum Gene. 2022;34:201132. doi: 10.1016/J.HUMGEN.2022.201132.", "ArticleIdList": ["10.1016/J.HUMGEN.2022.201132"]}, {"Citation": "Zhang Y, Liu C, Peng H, Zhang J, Feng Q. IL1 receptor antagonist gene IL1-RN variable number of Tandem Repeats Polymorphism and Cancer Risk: A literature review and Meta-analysis. PLoS ONE. 2012;7:46017. doi: 10.1371/JOURNAL.PONE.0046017.", "ArticleIdList": ["10.1371/JOURNAL.PONE.0046017", "PMC3457944", "23049925"]}, {"Citation": "Mommersteeg MC, Yu J, Peppelenbosch MP, Fuhler GM. Genetic Host Factors in Helicobacter Pylori-Induced carcinogenesis: emerging New paradigms. Biochim Biophys Acta Rev Cancer. 2018;1869:42\u201352. doi: 10.1016/J.BBCAN.2017.11.003.", "ArticleIdList": ["10.1016/J.BBCAN.2017.11.003", "29154808"]}, {"Citation": "R\u00e9b\u00e9 C, Ghiringhelli F. Interleukin-1\u03b2 and Cancer. Cancers (Basel) 2020;12:1\u201331. doi: 10.3390/CANCERS12071791.", "ArticleIdList": ["10.3390/CANCERS12071791", "PMC7408158", "32635472"]}, {"Citation": "Ren HY, Wen LS, Geng YH, Huang JB, Liu JF, Shen DY, Meng JR. Association between IL-1B gene polymorphisms and Helicobacter pylori infection: a meta-analysis. Microb Pathog. 2019;137. 10.1016/J.MICPATH.2019.103769.", "ArticleIdList": ["31580959"]}, {"Citation": "Wang X, Yin J, Zheng L, Wang L, Shi Y, Tang W, Ding G, Liu C, Liu R, Chen S, et al. The variant interleukin 1f7 Rs3811047 G\u2009&gt;\u2009A was Associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han Population. Tumor Biology. 2014;35:3509\u201315. doi: 10.1007/s13277-013-1463-y.", "ArticleIdList": ["10.1007/s13277-013-1463-y", "24357513"]}, {"Citation": "Hashemi M, Bahari G, Sarhadi S, Eskandari E, Narouie B, Taheri M, Ghavami S. Bp Insertion/Deletion (Rs3783553) polymorphism within the 3\u2019UTR of IL1A contributes to the risk of prostate Cancer in a Sample of Iranian Population. J Cell Biochem. 2018;119:4. doi: 10.1002/JCB.26427.", "ArticleIdList": ["10.1002/JCB.26427", "29023981"]}, {"Citation": "Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric Cancer: genetic susceptibility, Pathology, and implications for management. Lancet Oncol. 2015;16:e60\u201370. doi: 10.1016/S1470-2045(14)71016-2.", "ArticleIdList": ["10.1016/S1470-2045(14)71016-2", "25638682"]}, {"Citation": "Mentis AFA, Boziki M, Grigoriadis N, Papavassiliou AG. Helicobacter Pylori infection and gastric Cancer Biology: tempering a double-edged Sword. Cell Mol Life Sci. 2019;76:2477\u201386. doi: 10.1007/S00018-019-03044-1.", "ArticleIdList": ["10.1007/S00018-019-03044-1", "PMC11105440", "30783683"]}, {"Citation": "Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E, Hosoda F, Yachida S, Tsuji Y, Fujishiro M, Koike K, et al. Initial and crucial genetic events in Intestinal-Type Gastric Intramucosal Neoplasia. J Pathol. 2019;247:494\u2013504. doi: 10.1002/PATH.5208.", "ArticleIdList": ["10.1002/PATH.5208", "30474112"]}, {"Citation": "Carvalho J, Oliveira P, Senz J, S\u00e3o Jos\u00e9 C, Hansford S, Teles SP, Ferreira M, Corso G, Pinheiro H, Lemos D, et al. Redefinition of familial intestinal gastric Cancer: clinical and genetic perspectives. J Med Genet. 2021;58:1\u201311. doi: 10.1136/JMEDGENET-2019-106346.", "ArticleIdList": ["10.1136/JMEDGENET-2019-106346", "32066632"]}, {"Citation": "Cristescu R, Lee J, Nebozhyn M, Kim KM, Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al. Molecular Analysis of Gastric Cancer identifies subtypes Associated with distinct clinical outcomes. Nat Med. 2015;21:449\u201356. doi: 10.1038/NM.3850.", "ArticleIdList": ["10.1038/NM.3850", "25894828"]}, {"Citation": "Bellini MF, Cadamuro ACT, Succi M, Proen\u00e7a MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol. 2012;2012. 10.1155/2012/891961.", "ArticleIdList": ["PMC3420349", "22919278"]}, {"Citation": "de Almeida NM, Fernandes A, Rom\u00e3ozinho JM, Freire P, Donato MM, Cardoso O, Luxo C, Cipriano MA, Marinho C, Calhau C, et al. Correlation of NOD2 genotypes with Helicobacter Pylori Infection in a South-European Country. Adv Dig Med. 2021;8:163\u201371. doi: 10.1002/AID2.13210.", "ArticleIdList": ["10.1002/AID2.13210"]}, {"Citation": "Hanahan D, Weinberg RA. Hallmarks of Cancer: the next generation. Cell. 2011;144:646\u201374. doi: 10.1016/J.CELL.2011.02.013.", "ArticleIdList": ["10.1016/J.CELL.2011.02.013", "21376230"]}, {"Citation": "Siri G, Yazdani O, Esbati R, Akhavanfar R, Asadi F, Adili A, Ebrahimzadeh F, Hosseini SM. E. A Comprehensive Review of the role of LncRNAs in gastric Cancer (GC) Pathogenesis, Immune Regulation, and their clinical applications. Pathol Res Pract. 2023;241:154221. doi: 10.1016/J.PRP.2022.154221.", "ArticleIdList": ["10.1016/J.PRP.2022.154221", "36563559"]}, {"Citation": "Wroblewski LE, Peek RM, Wilson KT. Helicobacter Pylori and gastric Cancer: factors that modulate Disease Risk. Clin Microbiol Rev. 2010;23:713\u201339. doi: 10.1128/CMR.00011-10.", "ArticleIdList": ["10.1128/CMR.00011-10", "PMC2952980", "20930071"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "7"}, {"Year": "2024", "Month": "6", "Day": "4"}, {"Year": "2024", "Month": "6", "Day": "13", "Hour": "0", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "13", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "12", "Hour": "23", "Minute": "51"}, {"Year": "2024", "Month": "6", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["38867324", "PMC11167877", "10.1186/s13053-024-00282-8", "10.1186/s13053-024-00282-8"]}}]}